Since GLP-1s burst onto the scene in 2021 promising sustainable weight loss as high as 20%, this drug class has captured the public imagination like few before it. And yet, we’ve done little to understand consumer attitudes toward weight loss, their expressed needs or how they view GLP-1s vis-à-vis other weight loss solutions.
We got into the data to examine these attitudes, looking at millions of consumer datapoints to find out their motivations, wants and choice drivers across the weight management landscape. In this webinar, we look at how the insights we gleaned from this data can help pharmaceutical companies and other healthcare companies better plan commercialization efforts—from go-to-market strategies to consumer marketing and potential partnerships across weight management.
In this webinar we discuss:
- What ZS’s consumer intelligence platform reveals about consumer sentiment regarding weight management and weight management solutions
- A framework for understanding the weight management demand landscape, which captures what actually matters to healthcare consumers considering weight management solutions
- How this more nuanced view of consumer demand can inform everything from product development to consumer marketing and drive improved health outcomes by tapping into and even influencing consumer preferences
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
